Search research articles
Contact Us
Filters
Showing results (141-150 of 320) with videos related to
Page
of 32
Sort By:
Human Pathology
|
February 28, 2015
Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant
Ian Ganly, Laura Wang, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 13, 2015
Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare
Jennifer L Marti, Louise Davies, Megan R Haymart, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 2, 2010
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function
R Michael Tuttle, Norma Lopez, Rebecca Leboeuf, et al.
European Endocrinology
|
April 11, 2018
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine
Shrujal S Baxi, Rachel Kurtzman, Anne Eaton, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
July 26, 2003
Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents
Patricia A Powers, Catherine A Dinauer, R Michael Tuttle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2006
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer
R Michael Tuttle, Rebecca Leboeuf, Richard J Robbins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2016
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
Denise P Momesso, Fernanda Vaisman, Samantha P Yang, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
May 26, 2017
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary
José M Domínguez, Flavia Nilo, Tania Contreras, et al.
Annals of Clinical and Laboratory Science
|
June 24, 2003
Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary thyroid carcinoma in a nude mouse model
Andrew J Bauer, Aneeta Patel, Richard Terrell, et al.
Histopathology
|
April 27, 2022
The solid variant of papillary thyroid carcinoma: a multi-institutional retrospective study
Bin Xu, Kartik Viswanathan, Lingxin Zhang, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 320) with videos related to
Sort By:
Page
of 32
Human Pathology
|
February 28, 2015
Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant
Ian Ganly, Laura Wang, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 13, 2015
Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare
Jennifer L Marti, Louise Davies, Megan R Haymart, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 2, 2010
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function
R Michael Tuttle, Norma Lopez, Rebecca Leboeuf, et al.
European Endocrinology
|
April 11, 2018
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine
Shrujal S Baxi, Rachel Kurtzman, Anne Eaton, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
July 26, 2003
Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents
Patricia A Powers, Catherine A Dinauer, R Michael Tuttle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2006
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer
R Michael Tuttle, Rebecca Leboeuf, Richard J Robbins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2016
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
Denise P Momesso, Fernanda Vaisman, Samantha P Yang, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
May 26, 2017
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary
José M Domínguez, Flavia Nilo, Tania Contreras, et al.
Annals of Clinical and Laboratory Science
|
June 24, 2003
Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary thyroid carcinoma in a nude mouse model
Andrew J Bauer, Aneeta Patel, Richard Terrell, et al.
Histopathology
|
April 27, 2022
The solid variant of papillary thyroid carcinoma: a multi-institutional retrospective study
Bin Xu, Kartik Viswanathan, Lingxin Zhang, et al.
Page
of 32